Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
iTeos Therapeutics, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 130K | Mar 9, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ITOS | iTeos Therapeutics, Inc. | Mar 9, 2023 | 1 | $0 | 4 | Mar 10, 2023 | Chief Medical Officer |
ITOS | iTeos Therapeutics, Inc. | Mar 11, 2022 | 4 | -$111K | 4 | Mar 14, 2022 | Chief Medical Officer |
ITOS | iTeos Therapeutics, Inc. | Feb 11, 2022 | 4 | -$110K | 4 | Feb 14, 2022 | Chief Medical Officer |
ITOS | iTeos Therapeutics, Inc. | Jan 14, 2022 | 4 | -$123K | 4 | Jan 18, 2022 | Chief Medical Officer |
ITOS | iTeos Therapeutics, Inc. | Jan 3, 2022 | 3 | -$333K | 4 | Jan 4, 2022 | Chief Medical Officer |
ITOS | iTeos Therapeutics, Inc. | Dec 17, 2021 | 3 | -$257K | 4 | Dec 17, 2021 | Chief Medical Officer |
ITOS | iTeos Therapeutics, Inc. | Dec 10, 2021 | 3 | -$106K | 4 | Dec 10, 2021 | Chief Medical Officer |
ITOS | iTeos Therapeutics, Inc. | Nov 18, 2021 | 3 | -$846K | 4 | Nov 19, 2021 | Chief Medical Officer |
ITOS | iTeos Therapeutics, Inc. | Jun 24, 2021 | 1 | $0 | 4 | Jun 25, 2021 | Chief Medical Officer |